COMMUNIQUÉS West-GlobeNewswire

X-Chem Strengthens Executive Team with Strategic Finance and HR Appointments
17/06/2025
New leaders join X-Chem to support operational excellence and partner success across data-driven discovery programs WALTHAM, Mass., June 17, 2025 (GLOBE NEWSWIRE) -- X-Chem, a global leader in data-driven drug discovery [...]
Lipella Pharmaceuticals Announces U.S. Patent Issuance for Diagnostic Technology
17/06/2025
PITTSBURGH, June 17, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on developing therapies for diseases with [...]
Cannabix Technologies Receives Notice of Allowance from USPTO for Contactless Breath Analysis
17/06/2025
VANCOUVER, British Columbia, June 17, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) is pleased to report that the United States Patent and [...]
AIM ImmunoTech Resumes Trading on NYSE American
17/06/2025
Company trading under the ticker “AIM” NYSE American effective at the start of trading today, Tuesday, June 17th OCALA, Fla., June 17, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “ [...]
Ernst & Young LLP (EY US) Announces Jason Matuszewski, CEO of BioStem Technologies, as an Entrepreneur Of The Year® 2025 Florida Award Winner
17/06/2025
Award celebrates bold leaders shaping the future through the world’s most ground-breaking companies POMPANO BEACH, Fla., June 17, 2025 (GLOBE NEWSWIRE) -- Ernst & Young LLP (EY US) announced that Jason Matuszewski, [...]
Femasys Names New Chief Commercial Officer to Drive Execution and Global Growth
17/06/2025
--New CCO to Lead U.S. Commercialization of Fertility Products, Including FemaSeed ® , and Expand Strategic Global Partnerships Across Full Portfolio-- ATLANTA, June 17, 2025 (GLOBE NEWSWIRE) -- Femasys, Inc. (Nasdaq: [...]
Lark Health Names Industry Veteran Matthew Gibbs as President and Launches LarkVantage, an A.I. GLP-1 Cost Containment Platform
17/06/2025
Former PBM and health plan executive to spearhead innovative launch of a breakthrough A.I.-powered platform for streamlining GLP-1 authorization MOUNTAIN VIEW, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- Lark Health , a [...]
LogicMark, Inc. Appoints Jeffrey Durkin as Senior Vice President of Sales to Drive Strategic Growth in the Care Economy and Personal Safety Markets
17/06/2025
LOUISVILLE, Ky, June 17, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc. (the "Company"), a provider of personal emergency response systems (PERS), health communication devices, and technology for the growing safety and care [...]
BioAge Labs Expands Drug Discovery Platform with Data from Leading European Biobank
17/06/2025
Company to generate and analyze molecular profiles from over 17,000 samples from the HUNT Biobank in Norway to accelerate discovery of drug targets for aging-related diseases New data deepen platform insights into the [...]
Alira Health Launches Patient Engagement Certification for Life Sciences Organizations
17/06/2025
FRAMINGHAM, Mass., June 17, 2025 (GLOBE NEWSWIRE) -- Alira Health is a global healthcare consultancy that helps life sciences companies deliver patient-centered solutions through integrated clinical, strategic, and [...]
Capricor Therapeutics Announces Orphan Drug Designation for Becker Muscular Dystrophy and Regulatory Progress for Duchenne Muscular Dystrophy Program
17/06/2025
U.S. FDA grants Orphan Drug Designation to Deramiocel for the treatment of Becker Muscular Dystrophy, broadening Capricor’s focus in neuromuscular diseases Capricor remains on track for the August 31, 2025, PDUFA date [...]
Processa Pharmaceuticals Signs Binding Term Sheet Granting Intact Therapeutics Exclusive Option to License Phase 2 Gastroparesis Drug Candidate
17/06/2025
$452.5 million in total milestone payments $2.5 million in near-term payments Double-digit royalties on future net product sales 3.5% equity stake in Intact Therapeutics HANOVER, Md., June 17, 2025 (GLOBE NEWSWIRE) -- [...]
Omada Health’s Enhanced GLP-1 Care Track Demonstrates Increased Medication Persistence and Weight Loss Outcomes at 12 and 24 Weeks
17/06/2025
New GLP-1 analysis reveals that by addressing real-world barriers to persistence, Omada’s companion program can help sustain GLP-1 use, delivering on clinical trials' promises SAN FRANCISCO, June 17, 2025 (GLOBE [...]
Project Sunshine Announces "Longest Day of Play" Fundraising Campaign Planned for June 20th Alongside Refreshed Visual Identity
17/06/2025
NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Project Sunshine , an organization supporting children and families with medical needs through the power of play, is launching a major fundraising campaign on Friday, June [...]
BioRestorative Announces Share Repurchase Program
17/06/2025
MELVILLE, N.Y., June 17, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc . (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX ) , a clinical stage regenerative medicine innovator focused on stem cell-based [...]
Prime Biome Gummy: Examining the Science and Safety of a Legal Gut-Skin Health Formula
17/06/2025
LARGO, Fl, June 17, 2025 (GLOBE NEWSWIRE) -- Amid rising interest in gut health and its connection to overall wellness, a new supplement called Prime Biome Gummy has entered the market, offering a science-based approach [...]
FDA Grants Orphan Drug Designation to Medicovestor’s First-in-Class ADC for Pancreatic Cancer
17/06/2025
Novel chemoimmunotherapy platform aims to transform outcomes in one of the world’s deadliest cancers NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Medicovestor , Inc., a biotechnology company advancing next-generation [...]
USAHS & The Brain Center Unite to Support Dementia Caregivers with Hands-On Course
17/06/2025
The event offers immersive training and emotional support for family caregivers during Alzheimer’s & Brain Awareness Month. MIAMI, June 17, 2025 (GLOBE NEWSWIRE) -- In recognition of Alzheimer’s & Brain [...]
Lauréat de l’appel à projet Biothérapies et Bioproduction, du plan France 2030, EVerZom reçoit un financement de l’Etat de 3 millions d’euros pour industrialiser sa technologie de bioproduction d’exosomes
17/06/2025
Lauréat de l’appel à projet Biothérapies et Bioproduction, du plan France 2030, EVerZom reçoit un financement de l’Etat de 3 millions d’euros pour industrialiser sa technologie de bioproduction d’exosomes Paris, le 17 [...]

Pages